Add like
Add dislike
Add to saved papers

Substance P in Solution: Trans-to-Cis Configurational Changes of Penultimate Prolines Initiate Non-enzymatic Peptide Bond Cleavages.

We report ion mobility spectrometry and mass spectrometry studies of the non-enzymatic step-by-step degradation of substance P (subP), an 11-residue neuropeptide, with the sequence Arg1 -Pro2 -Lys3 -Pro4 -Gln5 -Gln6 -Phe7 -Phe8 -Gly9 -Leu10 -Met11 -NH2 , in ethanol. At elevated solution temperatures (55 to 75 °C), several reactions are observed, including a protonation event, i.e., [subP+2H]2+ + H+  → [subP+3H]3+ , that appears to be regulated by a configurational change and two sequential bond cleavages (the Pro2 -Lys3 peptide bond is cleaved to form the smaller nonapeptide Lys3 -Met11 -NH2 [subP(3-11) ], and subsequently, subP(3-11) is cleaved at the Pro4 -Gln5 peptide bond to yield the heptapeptide Gln5 -Met11 -NH2 [subP(5-11) ]). Each of the product peptides [subP(3-11) and subP(5-11) ] is accompanied by a complementary diketopiperazine (DKP): cyclo-Arg1 -Pro2 (cRP) for the first cleavage, and cyclo-Lys3 -Pro4 (cKP) for the second. Insight about the mechanism of degradation is obtained by comparing kinetics calculations of trial model mechanisms with experimental data. The best model of our experimental data indicates that the initial cleavage of subP is regulated by a conformational change, likely a trans→cis isomerization of the Arg1 -Pro2 peptide bond. The subP(3-11) product has a long lifetime (t1/2 ~ 30 h at 55 °C) and appears to transition through several structural intermediates prior to dissociation, suggesting that subP(3-11) is initially formed with a Lys3 -trans-Pro4 peptide bond configuration and that slow trans→cis isomerization regulates the second bond cleavage event as well. From these data and our model mechanisms, we obtain transition state thermochemistry ranging from ΔH‡  = 41 to 85 kJ mol-1 and ΔS‡  = - 43 to - 157 J mol-1  K-1 for each step in the reaction. Graphical Abstract.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app